Stay updated on ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page revision version was updated from v3.5.2 to v3.5.3 without changing the underlying study information presented.
    Difference
    0.1%
    Check dated 2026-04-24T16:56:09.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:45:08.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma as a study condition and a Genetic and Rare Diseases Information Center resource link. The page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-19T22:15:50.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:01:53.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Minor UI/layout adjustments and an updated timestamp; no substantive changes to core study content such as eligibility, primary outcomes, or treatment details.
    Difference
    0.1%
    Check dated 2026-03-05T14:40:03.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 is now visible. The funding lapse notice and the older Revision: v3.4.1 have been removed.
    Difference
    0.5%
    Check dated 2026-02-11T09:52:36.000Z thumbnail image

Stay in the know with updates to ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.